Authority inspection


Dear Stakeholders,

This is to inform you that we were inspected by the South Korean health authority from February 27.-29., 2024.
The audit has covered quality systems, equipment and facilities, materials, production, packaging,

labeling and laboratory controls for Active Pharmaceutical Ingredient and Drug Products.
We are proud to announce that the inspection was concluded successfully.

This proves again the continuous commitment of Excella GmbH & Co. KG to operate in full compliance with the guidelines of good manufacturing practice (GMP) and maintain excellent quality standards.

This is, once again, a great achievement and enforces our continuous commitment to quality and best practice at Excella.

Posted in Allgemein